3C Patch® is made from the patient's own blood with no additional reagents or additives. The three layer patch includes fibrin for moisture retention and strength, platelets for growth factor... More
Printer-friendly version
Autologous homologous delivery systems are used to process blood-derived growth factors (platelet-rich plasma) or full-thickness skin, used in the treatment of surgical, chronic, and traumatic wounds. Processing of autologous tissue is minimally invasive and is to be conducted at the point of care.
-
-
ActiGraft, a FDA-cleared regenerative wound care solution, enables health care providers to produce in vitro blood clots from a patient's whole blood. Once applied, the blood clot tissue serves as... More
-
The ART PRP® Plus system processes autologous blood at the point-of-care in 15 minutes. Essential growth factors and proteins are found within the stratified stack of the blood plasma. Also... More
-
The ART PRP® system processes autologous blood at the point-of-care in 15 minutes. Essential growth factors and proteins are found within the stratified stack of the blood plasma. More
-
Aurix™ is a biodynamic hematogel that harnesses a patient's innate healing mechanisms to jumpstart the natural healing process for a broad range of chronic non-healing wounds. More
-
SkinTE is a human cellular and tissue-based product derived from a patient's own skin to regenerate full-thickness, functionally-polarized skin with all of its layers (epidermis, dermis and... More